Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MCI-225 is a norepinephrine reuptake/5-HT3/5-HT reuptake inhibitor. MCI-225 could be effective in the treatment of senile dementia of the Alzheimer type, which is accompanied with both deficit in the BF-cortex cholinergic neuron and cerebral glucose hypometabolism. MCI-225 enhances attentional eye tracking in midpontine pretrigeminal preparation.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | MCI-225 is a norepinephrine reuptake/5-HT3/5-HT reuptake inhibitor. MCI-225 could be effective in the treatment of senile dementia of the Alzheimer type, which is accompanied with both deficit in the BF-cortex cholinergic neuron and cerebral glucose hypometabolism. MCI-225 enhances attentional eye tracking in midpontine pretrigeminal preparation. |
別名 | AA-10021, AA10021, MCI225, DDP-225, AA-10025, AA-10026 |
分子量 | 382.88 |
分子式 | C17H20ClFN4OS |
CAS No. | 476148-82-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MCI-225 hydrochloride hydrate 476148-82-0 AA-10021 AA10021 AA 10025 MCI-225 AA 10026 MCI225 DDP-225 MCI-225 hydrochloride Hydrate AA-10025 AA 10021 MCI 225 hydrochloride hydrate MCI225 hydrochloride hydrate AA-10026 DDP225 AA10026 MCI 225 AA10025 DDP 225 Inhibitor inhibitor inhibit